255 related articles for article (PubMed ID: 24596368)
1. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
[TBL] [Abstract][Full Text] [Related]
2. Phyllodes tumors and fibroadenoma common beginning and different ending.
Oprić S; Oprić D; Gugić D; Granić M
Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
Feakins RM; Wells CA; Young KA; Sheaff MT
Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
[TBL] [Abstract][Full Text] [Related]
4. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
6. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
Kocová L; Skálová A; Fakan F; Rousarová M
Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
10. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
11. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
[TBL] [Abstract][Full Text] [Related]
12. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
[TBL] [Abstract][Full Text] [Related]
13. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
14. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
16. Phyllodes tumor of the breast: an update.
Tse GM; Niu Y; Shi HJ
Breast Cancer; 2010; 17(1):29-34. PubMed ID: 19434472
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
[TBL] [Abstract][Full Text] [Related]
18. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
Umekita Y; Yoshida H
Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
[TBL] [Abstract][Full Text] [Related]
20. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
Veneti S; Manek S
Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]